NASDAQ · HINDHealthcarePharmaceuticals

Vyome Holdings financials

$2.02−0.49%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$319.7K
Gross profit$218.8K
Gross margin68.4%
Operating income-$10.5M
Net income-$10.5M
Net margin−3285.3%
Diluted EPS$-4.86
EBITDA-$10.4M
Operating cash flow-$3.7M
Free cash flow-$3.7M
Diluted shares2.2M

Balance sheet

Period endDec 31
Cash & equivalents$5.0M
Short-term investments$0.00
Total debt$0.00
Total assets$6.5M
Total liabilities$2.7M
Shareholders' equity$3.8M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology